Literature DB >> 8751949

Absolute identification of muramic acid, at trace levels, in human septic synovial fluids in vivo and absence in aseptic fluids.

A Fox1, K Fox, B Christensson, D Harrelson, M Krahmer.   

Abstract

This is the first report of a study employing the state-of-the-art technique of gas chromatography-tandem mass spectrometry for absolute identification of muramic acid (a marker for peptidoglycan) at trace levels in a human or animal body fluid or tissue. Daughter mass spectra of synovial fluid muramic acid peaks (> or = 30 ng/ml) were identical to those of pure muramic acid. Absolute chemical identification at this level represents a 1,000-fold increase in sensitivity over previous gas chromatography-mass spectrometry identifications. Muramic acid was positively identified in synovial fluids during infection and was eliminated over time but was absent from aseptic fluids.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8751949      PMCID: PMC174313          DOI: 10.1128/iai.64.9.3911-3915.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Yersinia-triggered reactive arthritis. Use of polymerase chain reaction and immunocytochemical staining in the detection of bacterial components from synovial specimens.

Authors:  S Nikkari; R Merilahti-Palo; R Saario; K O Söderström; K Granfors; M Skurnik; P Toivanen
Journal:  Arthritis Rheum       Date:  1992-06

2.  Mass spectrometric quantitation of muramic acid, a bacterial cell wall component, in septic synovial fluids.

Authors:  B Christensson; J Gilbart; A Fox; S L Morgan
Journal:  Arthritis Rheum       Date:  1989-10

3.  The metabolic fate of 14C-labeled peptidoglycan monomer in mice. I. Identification of the monomer and the corresponding pentapeptide in urine.

Authors:  J Tomasić; B Ladesić; Z Valinger; I Hrsak
Journal:  Biochim Biophys Acta       Date:  1980-04-17

4.  The metabolic fate of 14C-labeled immunoadjuvant peptidoglycan monomer. II. In vitro studies.

Authors:  B Ladesić; J Tomasić; S Kveder; I Hrsak
Journal:  Biochim Biophys Acta       Date:  1981-11-18

5.  Recurrent anterior uveitis induced by multiple systemic injections of muramyl dipeptide.

Authors:  T Li; K Fox; A Fox; V Pakalnis
Journal:  Exp Eye Res       Date:  1993-07       Impact factor: 3.467

6.  Detection of Chlamydia trachomatis DNA in joints of reactive arthritis patients by polymerase chain reaction.

Authors:  D Taylor-Robinson; C B Gilroy; B J Thomas; A C Keat
Journal:  Lancet       Date:  1992-07-11       Impact factor: 79.321

7.  Somnogenic activity of O-acetylated and dimeric muramyl peptides.

Authors:  L Johannsen; R S Rosenthal; S A Martin; A B Cady; F Obal; M Guinand; J M Krueger
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

8.  Muramic acid detection in mammalian tissues by gas-liquid chromatography-mass spectrometry.

Authors:  A Fox; J H Schwab; T Cochran
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

9.  Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouse.

Authors:  M Parant; F Parant; L Chedid; A Yapo; J F Petit; E Lederer
Journal:  Int J Immunopharmacol       Date:  1979

10.  Rapid elimination of a synthetic adjuvant peptide from the circulation after systemic administration and absence of detectable natural muramyl peptides in normal serum at current analytical limits.

Authors:  A Fox; K Fox
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

View more
  7 in total

Review 1.  How can a causal role for small bacteria in chronic inflammatory arthritides be established or refuted?

Authors:  D Taylor-Robinson; A Keat
Journal:  Ann Rheum Dis       Date:  2001-03       Impact factor: 19.103

2.  Molecular mimicry revisited: gut bacteria and multiple sclerosis.

Authors:  Fred C Westall
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

Review 3.  Mass spectrometry for species or strain identification after culture or without culture: Past, present, and future.

Authors:  Alvin Fox
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

Review 4.  Use of gas chromatography-ion trap tandem mass spectrometry for the detection and characterization of microorganisms in complex samples.

Authors:  L Larsson; A Saraf
Journal:  Mol Biotechnol       Date:  1997-06       Impact factor: 2.695

5.  Muramic acid is not generally present in the human spleen as determined by gas chromatography-tandem mass spectrometry.

Authors:  Michael P Kozar; Jon D Laman; Alvin Fox
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

6.  Failure To detect muramic acid in normal rat tissues but detection in cerebrospinal fluids from patients with Pneumococcal meningitis.

Authors:  M P Kozar; M T Krahmer; A Fox; B M Gray
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

7.  Uptake, recognition and responses to peptidoglycan in the mammalian host.

Authors:  Paulo A D Bastos; Richard Wheeler; Ivo G Boneca
Journal:  FEMS Microbiol Rev       Date:  2021-01-08       Impact factor: 16.408

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.